Nebivolol

🧮 Dose calculator

Hypertension · Regimen source: FDA Nebivolol · 2.1

• • Increase at 2-week intervals as needed up to 40 mg. CrCl <30: start 2.5 mg. FDA Nebivolol · 2.1

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Nebivolol · 8.1

  “Risk Summary Available data regarding use of nebivolol tablets in pregnant women are insufficient to determine whether there are drug-associated risks of adverse developmental outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Nebivolol · 8.2

  “Risk Summary There is no information regarding the presence of nebivolol in human milk, the effects on the breastfed infant, or the effects on milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Nebivolol · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsNo specific problem stated

  Label: no specific difference or dose adjustment stated for older adults. FDA Nebivolol · 8.5

  “No overall differences in efficacy or in the incidence of adverse events were observed between older and younger patients.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.